![Christina Ackermann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christina Ackermann
Directeur/Membre du Conseil chez
SYNERGETICS USA INC
Fortune : 148 218 $ au 31/05/2026
Profil
Christina Maria Ackermann is currently Secretary & Director at Synergetics USA, Inc., Co-Managing Director at Dr. Robert Winzer Pharma GmbH since 2017, and Independent Non-Executive Director at Oculis Holding AG since 2023.
Former positions include Chairman at Virometix AG (2022–2023), Independent Director at Graybug Vision, Inc. (2021–2023), Independent Non-Executive Director at Verona Pharma Ltd. (2023–2025), Associate General Counsel at DuPont Pharmaceuticals Co. (1996–2000), Senior Vice President & General Counsel at Alcon Laboratories, Inc. (2012–2016), General Counsel & Global Head-Legal at Sandoz International GmbH (2007–2012), Associate General Counsel at Bristol-Myers Squibb Pharma Co. (2001–2002), Head-Legal Technical Operations & Ophthalmics at Novartis Pharma AG (2002–2005), President, Executive VP & General Counsel at Bausch + Lomb Corp.
(2022–2023), and Head-Commercial Operations at Bausch Health Cos., Inc. (2020–2022).
Education includes undergraduate studies at York University and graduate degrees from Queen's University and King's College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCULIS HOLDING AG 0,01 % | 31/12/2025 | 6 528 ( 0,01 % ) | 148 218 $ | 31/05/2026 |
Postes actifs de Christina Ackermann
| Sociétés | Poste | Début |
|---|---|---|
| SYNERGETICS USA INC | Directeur/Membre du Conseil | - |
| OCULIS HOLDING AG | Directeur/Membre du Conseil | 03/03/2023 |
Dr. Robert Winzer Pharma GmbH
 Dr. Robert Winzer Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 27/02/2017 |
Anciens postes connus de Christina Ackermann
| Sociétés | Poste | Fin |
|---|---|---|
| VERONA PHARMA PLC | Directeur/Membre du Conseil | 07/10/2025 |
Virometix AG
 Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Président | 01/05/2023 |
| BAUSCH + LOMB CORPORATION | President | 24/04/2023 |
| CALCIMEDICA, INC. | Directeur/Membre du Conseil | 01/03/2023 |
| BAUSCH HEALTH COMPANIES INC. | Conseiller Juridique Général | 01/07/2020 |
Formation de Christina Ackermann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synergetics USA, Inc.
 Synergetics USA, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and supplies precision surgical devices | Health Technology |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Pharma Co. | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Dr. Robert Winzer Pharma GmbH
Dr. Robert Winzer Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Health Technology |
Bausch + Lomb Corp.
 Bausch + Lomb Corp. Medical SpecialtiesHealth Technology Manufactures and sells eye care products | Health Technology |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
